BIOCQ Biocept Inc.

USD 0.00 0.00 0
Icon

Biocept Inc. (BIOCQ) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.0001

0.00 (0.00)%

N/A

N/A

N/A

N/A

Icon

BIOCQ

Biocept Inc. (USD)
COMMON STOCK | NSD
USD 0.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

USD 0.00

Biocept Inc. (BIOCQ) Stock Forecast

N/A

Based on the Biocept Inc. stock forecast from 0 analysts, the average analyst target price for Biocept Inc. is not available over the next 12 months. Biocept Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biocept Inc. is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, Biocept Inc.’s stock price was USD 0.0001. Biocept Inc.’s stock price has changed by +0.00% over the past week, +0.00% over the past month and 0% over the last year.

No recent analyst target price found for Biocept Inc.
No recent average analyst rating found for Biocept Inc.

Company Overview Biocept Inc.

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays ...Read More

https://biocept.com

9955 Mesa Rim Road, San Diego, CA, United States, 92121

50

December

USD

USA

Adjusted Closing Price for Biocept Inc. (BIOCQ)

Loading...

Unadjusted Closing Price for Biocept Inc. (BIOCQ)

Loading...

Share Trading Volume for Biocept Inc. Shares

Loading...

Compare Performance of Biocept Inc. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIOCQ

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biocept Inc. (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc +3.22 (+0.68%) USD44.10B 52.65 36.72

ETFs Containing BIOCQ

Symbol Name BIOCQ's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biocept Inc. (BIOCQ) Stock

Stock Target Advisor's fundamental analysis for Biocept Inc.'s stock is Neutral.

Unfortunately we do not have enough data on BIOCQ's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIOCQ's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BIOCQ's stock to indicate if its overvalued.

The last closing price of BIOCQ's stock was USD 0.00.

Unfortunately we do not currently have any market capitalization data for BIOCQ's stock.

Unfortunately we do not have enough analyst data on BIOCQ's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biocept Inc.'s stock.

As per our most recent records Biocept Inc. has 50 Employees.

Biocept Inc.'s registered address is 9955 Mesa Rim Road, San Diego, CA, United States, 92121. You can get more information about it from Biocept Inc.'s website at https://biocept.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...